Dose-ranging Study

NCT01712451 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Abdominal Contour Defects

Interventions

DRUG: salmeterol xinafoate, fluticasone propionate
DRUG: Placebo
DRUG: salmeterol xinafoate

Sponsor

Neothetics, Inc